Movement Disorders (revue) - Checkpoint (PascalFrancis)

Index « Keywords » - entrée « Neuroprotective agent »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neuropile < Neuroprotective agent < Neuropsychiatry  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000123 (2012) Maryka Quik [États-Unis] ; Xiomara A. Perez [États-Unis] ; Tanuja Bordia [États-Unis]Nicotine as a Potential Neuroprotective Agent for Parkinson's Disease
002621 (2002) Johannes Schiefer [Allemagne] ; G. Bernhard Landwehrmeyer [Allemagne] ; Hans-Gerd Lüesse [Allemagne] ; Arne Sprünken [Allemagne] ; Christiane Puls [Allemagne] ; Anna Milkereit [Allemagne] ; Eva Milkereit [Allemagne] ; Christoph M. Kosinski [Allemagne]Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease
002680 (2002) Maria C. Obinu [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Assunta Imperato [France]Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence
002716 (2002) Paul Morrish [Royaume-Uni]Is it time to abandon functional imaging in the study of neuroprotection?
002808 (2002) DA agonists: ergot derivatives: Bromocriptine
002898 (2001) Arthur Korten [Pays-Bas] ; Jan Lodder [Pays-Bas] ; Fred Vreeling [Pays-Bas] ; Anita Boreas [Pays-Bas] ; Lisette Van Raak [Pays-Bas] ; Fons Kessels [Pays-Bas]Stroke and idiopathic Parkinson's disease : Does a shortage of dopamine offer protection against stroke?
002911 (2001) Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Feger [France]Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain
002A36 (2001) Krishna P. Datla [Royaume-Uni] ; Stavia B. Blunt [Royaume-Uni] ; David T. Dexter [Royaume-Uni]Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl3 nigrostriatal lesions
002E65 (1999) E. Grünblatt [Israël] ; S. Mandel [Israël] ; T. Berkuzki [Israël] ; M. B. H. Youdim [Israël]Apomorphine protects against MPTP-induced neurotoxicity in mice
002E93 (1998) I. Shoulson [États-Unis]Where do we stand on neuroprotection? Where do we go from here?
003046 (1998) C. W. Olanow [États-Unis] ; C. Mytilineou [États-Unis] ; W. Tatton [États-Unis]Current status of selegiline as a neuroprotective agent in Parkinson's disease
003080 (1998) M. Gassen [Allemagne] ; A. Gross [Israël] ; M. B. H. Youdim [Israël]Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
003081 (1998) M. Gassen [Israël] ; A. Gross [Israël] ; M. B. H. Youdim [Israël]Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i -k "Neuroprotective agent" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i  \
                -Sk "Neuroprotective agent" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Neuroprotective agent
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024